X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Aventis Pharma with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ACTAVIS (US) - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ACTAVIS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ACTAVIS
Dec-18
SANOFI INDIA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs6,84013,493-   
Low Rs4,6309,051-   
Sales per share (Unadj.) Rs1,203.13,309.8-  
Earnings per share (Unadj.) Rs165.3-1,066.1-  
Cash flow per share (Unadj.) Rs209.9348.8-  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.613,651.2-  
Shares outstanding (eoy) m23.03332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.83.4 140.0%   
Avg P/E ratio x34.7-10.6 -328.2%  
P/CF ratio (eoy) x27.332.3 84.6%  
Price / Book Value ratio x6.00.8 720.8%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,0783,749,019 3.5%   
No. of employees `0003.316.9 19.5%   
Total wages/salary Rs m4,0680-   
Avg. sales/employee Rs Th8,393.865,137.7 12.9%   
Avg. wages/employee Rs Th1,232.40-   
Avg. net profit/employee Rs Th1,153.0-20,980.9 -5.5%   
INCOME DATA
Net Sales Rs m27,7081,100,828 2.5%  
Other income Rs m89721,051 4.3%   
Total revenues Rs m28,6051,121,879 2.5%   
Gross profit Rs m6,23528,847 21.6%  
Depreciation Rs m1,027470,580 0.2%   
Interest Rs m763,524 0.0%   
Profit before tax Rs m6,098-484,205 -1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0123,492 0.0%   
Tax Rs m2,292-6,136 -37.4%   
Profit after tax Rs m3,806-354,577 -1.1%  
Gross profit margin %22.52.6 858.7%  
Effective tax rate %37.61.3 2,965.9%   
Net profit margin %13.7-32.2 -42.6%  
BALANCE SHEET DATA
Current assets Rs m15,922451,502 3.5%   
Current liabilities Rs m6,235399,413 1.6%   
Net working cap to sales %35.04.7 738.9%  
Current ratio x2.61.1 225.9%  
Inventory Days Days6420 325.0%  
Debtors Days Days2166 31.5%  
Net fixed assets Rs m7,539124,608 6.1%   
Share capital Rs m2300-   
"Free" reserves Rs m21,9620-   
Net worth Rs m22,1924,540,399 0.5%   
Long term debt Rs m01,598,839 0.0%   
Total assets Rs m29,8397,097,677 0.4%  
Interest coverage x872.1-6.6 -13,169.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.2 598.7%   
Return on assets %12.8-4.1 -311.6%  
Return on equity %17.2-7.8 -219.6%  
Return on capital %27.5-4.8 -568.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4420-   
CASH FLOW
From Operations Rs m3,739393,284 1.0%  
From Investments Rs m-731216,058 -0.3%  
From Financial Activity Rs m-1,972-674,993 0.3%  
Net Cashflow Rs m1,036-65,323 -1.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 69.73 Rs / USD

Compare SANOFI INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: FRESENIUS KABI ONCO.  DR. DATSONS LABS  TORRENT PHARMA  BIOCON   FULFORD INDIA  



Today's Market

Sensex Slips 300 Points; Tata Steel & Vedanta Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note. Barring IT sector, all sectoral indices are trading in red with stocks in the metal sector.

Related Views On News

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

FM Nirmala Sitharaman Inherits an Economy Facing a Number of Headwinds(Sector Info)

Jun 4, 2019

The Indian economy is in a major slowdown. Will the new finance minister, Nirmala Sitharaman bring the much-needed reforms?

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 17, 2019 02:01 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - ASTRAZENECA PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS